Colocalization and Sequential Enzyme Activity in Aqueous Biphasic Systems: Experiments and Modeling  by Davis, Bradley W. et al.
2182 Biophysical Journal Volume 109 November 2015 2182–2194ArticleColocalization and Sequential Enzyme Activity in Aqueous Biphasic
Systems: Experiments and ModelingBradley W. Davis,1 William M. Aumiller, Jr.,1 Negar Hashemian,2 Songon An,1 Antonios Armaou,2,*
and Christine D. Keating1,*
1Department of Chemistry and 2Department of Chemical Engineering, The Pennsylvania State University, University Park, PennsylvaniaABSTRACT Subcellular compartmentalization of biomolecules and their reactions is common in biology and provides a gen-
eral strategy for improving and/or controlling kinetics in metabolic pathways that contain multiple sequential enzymes. Enzymes
can be colocalized in multiprotein complexes, on scaffolds or inside subcellular organelles. Liquid organelles formed by intracel-
lular phase coexistence could provide an additional means of sequential enzyme colocalization. Here we use experiment and
computation to explore the kinetic consequences of sequential enzyme compartmentalization into model liquid organelles in
a crowded polymer solution. Two proteins of the de novo purine biosynthesis pathway, ASL (adenylosuccinate lyase, Step 8)
and ATIC (5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase, Steps 9
and 10), were studied in a polyethylene glycol/dextran aqueous two-phase system. Dextran-rich phase droplets served as model
liquid compartments for enzyme colocalization. In this system, which lacks any specific binding interactions between the phase-
forming polymers and the enzymes, we did not observe significant rate enhancements from colocalization for the overall reaction
under our experimental conditions. The experimental results were used to adapt a mathematical model to quantitatively describe
the kinetics. The mathematical model was then used to explore additional, experimentally inaccessible conditions to predict
when increased local concentrations of enzymes and substrates can (or cannot) be expected to yield increased rates of product
formation. Our findings indicate that colocalization within these simplified model liquid organelles can lead to enhanced meta-
bolic rates under some conditions, but that very strong partitioning into the phase that serves as the compartment is necessary.
In vivo, this could be provided by specific binding affinities between components of the liquid compartment and the molecules to
be localized within it.INTRODUCTIONEnzymes of metabolic pathways often exist as multienzyme
complexes that are spatially organized within different
cellular compartments or organelles (1). Substrate chan-
neling through multienzyme complexes offers many advan-
tages such as the transfer of metabolites from one active site
to the next without diffusing throughout the rest of the
cell, the sequestration of toxic or labile intermediates, and
the reduction of competing reactions from other enzymes
(2–4). Sequential enzymes can colocalize by binding to
each other or to a scaffold such as another protein, mem-
brane, or cytoskeletal component (5–7). The citric acid cy-
cle is a hallmark example of a scaffold-bound multienzyme
complex in which all of the enzymes are bound to the inner
mitochondrial membrane (8,9). Recent reports of liquid-like
organelles in both cytoplasm and nucleoplasm of eukaryoticSubmitted April 27, 2015, and accepted for publication September 21, 2015.
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These liquid organelles are thought to be the result of intra-
cellular phase separation, and therefore simple partitioning
of enzymes into one of the coexisting phases could offer a
means of enzyme colocalization in which enzymes need
not be bound to a scaffold. Hence, specific or nonspecific
binding interactions with components of the compartment
would not be required, but could also be present.
Artificial colocalization of sequential enzymes has been
achieved using a variety of scaffolds, such as proteins
(13,14), nanoparticles (15–17), nanostructured DNA (18),
nanostructured RNA (19), and microfluidic channels (20).
Many of these approaches have resulted in increased reac-
tion rates and product flux (1,21,22) and have provided
insight into the design of artificial multienzyme complexes
for industrial synthesis of valuable molecules, such as bio-
fuels (23). Colocalization of two enzymes does not always
guarantee that a large increase in overall reaction rate will
be observed (24,25). The interenzyme distance, enzyme
active site orientation, and relative activities of the enzymes
can affect the catalytic efficiency of an artificial multi-
enzyme complex (25). There has been considerably less
effort toward the study of in vitro liquid compartments for
multiple enzyme colocalization. Freely-diffusing enzymeshttp://dx.doi.org/10.1016/j.bpj.2015.09.020
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compartment are presumably not as fully colocalized as
are enzymes bound to a shared scaffold, and have neither
fixed separation nor orientation with respect to each other.
Thus, differences in the kinetic consequences of colocaliza-
tion can be anticipated between these systems.
An aqueous two-phase system (ATPS) where biomole-
cules concentrate into one phase by partitioning can serve
as an in vitro model system for artificial liquid organelles
(26–28). One or both phases in which biochemical reac-
tions can occur is macromolecularly crowded, providing
excluded volume and chemical interactions, which is remi-
niscent of the intracellular milieu. Macromolecular crowd-
ing can alter enzyme conformation, substrate binding, etc.,
and has been reported to increase, decrease, or not change
enzyme activity, depending on the system (29–33). In addi-
tion to crowding, enzymes can be concentrated into one
phase of the ATPS, resulting in higher local concentration
and concomitant rate increases (34,35). Few examples of
sequential enzyme colocalization in ATPS have appeared.
Crosby et al. (36) observed an 18-fold increase in product
yield when the actinorhodin polyketide synthase complex
and its substrate were partitioned in poly(diallyldimethyl-
ammonium chloride)/ATP coacervates; the coacervate ma-
trix helped stabilize the complex. When glucose oxidase
and horseradish peroxidase were partitioned in a PEG/cit-
rate ATPS, sequential activity was limited due to accumula-
tion of the enzymes in a different phase from the substrate,
such that reaction could only occur at the interface (37). In
both sequential reaction examples, only one of the phases
was macromolecularly crowded, unlike intracellularly
where all liquid phases are expected to contain substantial
biopolymer concentrations. Here, we used a PEG/dextran
ATPS in which both phases are crowded with macromole-
cules. When mixed, the result is dextran-rich phase droplets
dispersed within a continuous PEG-rich phase. The dextran-
rich phase droplets serve as model liquid compartments that
contain a local high concentration of enzyme because of
simple partitioning, rather than any specific biorecognition.
We investigate two sequential enzymes from the de novo
purine biosynthetic pathway in the PEG/dextran ATPS. The
purine pathway in humans consists of six proteins with 10
enzymatic steps, with the final step being the synthesis of
IMP (inosine monophosphate). The enzymes of this pathway
have been shown to reversibly colocalize in vivo (38),
forming structures termed ‘‘purinosomes’’. Purinosomes
are visualized as cytoplasmic puncta that vary in size and
shape (0.2–0.9 mm) (39). Purinosome assembly is thought
to be mediated by interactions with microtubules and pro-
tein-protein interactions in which several pathway enzymes
serve as a scaffold for assembly of the rest (40–42). These
structures have not been considered to be liquid organelles,
and indeed some researchers suggest that they could
be aggregated protein/stress bodies (43,44). Purinosomes,
nonetheless, were recently shown to share some importantfeatures with liquid phase domains in terms of compartment
size, absence of a delimiting membrane, and their transient
nature (39,42). Additionally, purinosome formation corre-
lates with pathway activity, indicating a kinetic advantage
to enzyme colocalization in these bodies (4,40,45). The local
concentration increase of these enzymes due to purinosome
formation has not been quantified, but published images indi-
cate that while the signal due to labeled enzymes is strongest
in the purinosomes, some enzyme remains free in the cyto-
plasm (38,42). In addition, unrelated to this pathway, incom-
plete compartmentalization has been quantified for other
proteins, for example for the proteasome subunit Pre9, which
partitions between the cytoplasm and membrane of yeast
(46). Our model system allows us to investigate the effect
of incomplete compartmentalization on sequential enzyme
reactions.
Two proteins from the pathway, ASL (adenylosuccinate
lyase, Step 8) and ATIC (5-aminoimidazole-4-carboxamide
ribonucleotide transformylase/inosine monophosphate cy-
clohydrolase, Steps 9 and 10) are investigated here. ASL
and ATIC were chosen for this study because, in addition
to partitioning in vivo between the purinosomes and their
surroundings (42), both enzymes are relatively stable in
buffer solution, and they have been expressed, purified,
and characterized previously (47,48). They are found to be
associated with each other (and the rest of the purinosome)
(41), and the AICAR substrate is commercially available.
The enzymes partition into the dextran-rich phase of a
PEG/dextran ATPS. By decreasing the relative volume of
the dextran-rich phase to the PEG-rich phase (34), enzymes
were increasingly colocalized to that phase. The resulting
sequential enzyme activity was similar, regardless of the
volume of the dextran-rich phase. Experimental results
could be understood in the framework of a mathematical
model that also enabled prediction of additional conditions
not amenable to experiment.MATERIALS AND METHODS
Materials
Human ASL plasmid DNA and human ATIC (AICAR transformylase/
IMP cyclohydrolase) plasmid DNA were provided by the Stephen J. Ben-
kovic group at Pennsylvania State University (University Park, PA).
Poly(ethylene glycol) 8000 Da, dextran from Leuconostoc mesenteroides
9000–11,000 Da, AICAR (5-aminoimidazole-4-carboxamide ribonucleo-
tide), potassium chloride, glycine, lysozyme, sodium dodecyl sulfate,
Coomassie Plus Reagent (Thermo Fisher Scientific, Waltham, MA), DL-di-
thiothreitol, bromophenol blue, Amicon Ultracel filters (MWCO 10 kDa;
EMD Millipore, Billerica, MA), Trizma base, and Trizma hydrochloride
were purchased from Sigma-Aldrich (St. Louis, MO). Rosetta 2(DE3)
pLysS competent Escherichia coli cells and BL21 (DE3) competent
E. coli cells were from Novagen (Madison, WI). Yeast extract, tryptone,
agar, PMSF (phenylmethylsulfonyl fluoride), acrylamide/bis-acrylamide
19:1, TLC PEI cellulose F plates, ammonium acetate, ammonium hydrox-
ide, methanol, potassium phosphate monobasic, and potassium phosphate
dibasic were acquired from EMD Chemicals (Darmstadt, Germany).
Kanamycin sulfate was obtained from Calbiochem (Darmstadt, Germany).Biophysical Journal 109(10) 2182–2194
2184 Davis et al.Complete EDTA-free protease inhibitor cocktail tablets were purchased
from Roche (Indianapolis, IN). Ni-NTA His-Bind resin was obtained
from Qiagen (Hilden, Germany). Tetramethylethylenediamine was pur-
chased from IBI Scientific (Peosta, IA). Glacial acetic acid and fumaric
acid were acquired from Mallinckrodt Baker (Phillipsburg, NJ). Glycerol
and sodium chloride were obtained from BDH Chemicals (West Chester,
PA). Slide-A-Lyzer dialysis cassettes (MWCO 10 kDa) and albumin stan-
dards were acquired from Thermo Fisher Scientific. Alexa Fluor 488 C5
maleimide, Alexa Fluor 647 NHS ester labeling kit, and 13 mm Secure-
Seal Spacers were purchased from Life Technologies (Carlsbad, CA).
mPEG-NH2 MW 5000 was obtained from Shearwater Polymers (Hunts-
ville, AL). Deionized water with a resistivity of 18.2 MU-cm from a
NANOpure Diamond Water Purification System (Barnstead, Van Nuys,
CA) was used for all experiments. Buffers were filtered using 0.45 mm
pore size Nalgene filter units (Nalge Nunc, Rochester, NY). All reagents
were used as received without further purification.
Expression and purification of enzymes
N-terminal hexahistidine-tagged ASL plasmid DNA in a pET-28 vector was
transformed into Rosetta 2(DE3)pLysS competent E. coli cells according to
the Novagen protocol and was expressed and purified as reported by Lee
and Colman (47) with several adaptations. The cell pellet (~1 g wet cell pel-
let per 500 mL cell culture) was dissolved in 50 mL of 50 mM potassium
phosphate, pH 8.0, 300 mM potassium chloride, and 10% glycerol lysis
buffer. A protease inhibitor cocktail tablet of 10 mg/mL phenylmethylsul-
fonyl fluoride and 1 mg/mL lysozyme were added and the mixture was
stirred for 30 min. The mixture was sonicated on ice using a model No.
S-4000 Sonicator (Misonix, Farmingdale, NY). Pulse durations of 15 s at
50% amplitude were followed by a 45 s delay between pulses where the so-
lution was placed in an ice bath, for a total pulse time of 5 min. Cell debris
was removed by centrifugation (15,000  g for 30 min at 4C). The cell
lysate was incubated with Ni(II)-NTA resin and 1% Triton X-100 to inhibit
nonspecific protein binding for at least 1 h on an orbital shaker. The cell
lysate was transferred to a column and the Ni(II)-NTA resin was washed
with one-column volume of lysis buffer and subsequently washed with
one-column volume of 20-mM imidazole to remove nonspecific protein
binding. A 10-step gradient of lysis buffer to 500 mM imidazole with lysis
buffer was used to elute ASL in 10 mL increments and protein purity was
determined with sodium dodecyl sulfate polyacrylamide gel electropho-
resis. Pure fractions of ASL were concentrated to ~20% the original volume
with centrifugal filter units (MWCO 10 kDa) and dialyzed against a 50 mM
potassium phosphate, pH 7.0, 150 mM potassium chloride, 1 mM dithio-
threitol, 10% glycerol storage buffer to be stored in small enzyme aliquots
at 80C. Enzyme concentration was determined by the standard Bradford
assay utilizing a 1.5 mL Coomassie Plus Reagent (Thermo Fisher Scienti-
fic) and 50 mL of sample.
The pET-28 N-terminal hexahistidine-tagged ATIC vector was trans-
formed into BL21 (DE3) competent E. coli cells as instructed by Novagen
protocol. ATIC was subsequently expressed and purified as indicated by
Wolan et al. (48). Cell lysis and enzyme purification was done as described
for ASL with lysis buffer (50 mM sodium phosphate, pH 8.0, 300 mM so-
dium chloride, and 20 mM imidazole). After the pure fractions were
concentrated, ATIC was dialyzed against a 20 mM Tris (pH 7.5),
150 mM sodium chloride, and 50 mM potassium chloride buffer. ATIC
was quantified by the Bradford assay and was stored in aliquots at 4C.
SAICAR synthesis
SAICAR was prepared and purified as described by Zika´nova´ et al. (49)
with several adaptations. Fumaric acid stock solutions were prepared in
the reaction buffer and adjusted to pH 7.0 with sodium hydroxide (50).
The 1 mL reaction volume contained 2.6 mM AICAR and 20 mM fumaric
acid in a 10 mM Tris, pH 7.5, 10 mM potassium chloride buffer (49). The
final concentration of ASL was 0.4 mg/mL and the reactions were allowed
to proceed for 5 h at room temperature. Enzyme was removed by centrifu-
gal filter units (MWCO 10 kDa) and the reaction mixture was concentratedBiophysical Journal 109(10) 2182–2194to 100 mL via a Savant DNA 120 Speed Vac (Thermo Fisher Scientific) at
ambient temperature. Higher temperature settings yielded the pink com-
pound described by van den Bergh (51). Aliquots of 20 mL were spotted
on PEI-cellulose TLC plates to provide adequate separation of the concen-
trated product with 1 M ammonium acetate. Product was eluted with 2 mL
of 1 M ammonium hydroxide overnight on an orbital shaker and the super-
natant was subsequently evaporated to dryness with a Savant DNA 120
Speed Vac (Thermo Fisher Scientific). SAICAR was resuspended in
33 mM Tris buffer, pH 7.4, 25 mM potassium chloride and the concentra-
tion was determined spectrophotometrically at 269 nm using the molar
extinction coefficient 13.1  103 M1 cm1 (49). Aliquots were stored
at 80C.
10-fTHF synthesis
The cofactor 10-formyltetrahydrofolic acid was prepared as described by
Rabinowitz (52) and Rowe (53). After purification, aliquots were stored
at 80C. Concentrations were determined before use by spectrophotom-
etry using the extinction coefficient of 9540 M1 cm1 (54).
ATPS preparation
For binodal determination, separate 25% (w/w) PEG 8 kDa and 25% (w/w)
dextran 10 kDa stock solutions were prepared with 33 mM Tris, pH 7.4,
25 mM potassium chloride buffer (55) and samples with varying percent-
ages of polymers were prepared near the expected binodal to determine
at which concentrations the phase separation occurred. For assays and par-
titioning experiments, a 10% (w/w) PEG 8 k and 10% (w/w) dextran 10 k in
the same buffer was prepared and physically separated. The phases were
then recombined at the desired PEG/dextran volume ratios. Samples were
subsequently concentrated by a Speed Vac (Thermo Fisher Scientific) so
that upon addition of enzymes and/or substrates, the ATPS would be diluted
to its original concentration. This ensures the reconstituted volume ratios
remain on the same tie line and was done for all described experiments.
The viscosity of the phases was measured with an Ostwald viscometer.
Phase composition determination
The polymer composition of each phase was determined using a combina-
tion of refractometry and polarimetry (56). Refractive index measurements
were done using an Abbe Autorefractometer (Leica Geosystems, Norcross,
GA). Polarimetry measurements were done using a model No. 343 Polarim-
eter (PerkinElmer, Billerica, MA). The concentration of dextran 10 kDa
was determined by polarimetry, using a standard curve of known concentra-
tions of dextran. The concentration of PEG was determined using refrac-
tometry. Calibration curves of known weight percents of PEG 8 kDa and
dextran 10 kDa were prepared, and the refractive index of each of the stan-
dards and the PEG-rich and dextran-rich phases was measured. The contri-
bution of the refractive index from dextran was subtracted from the total
refractive index and the remaining refractive index was attributed to PEG
8 kDa.
Partitioning coefficients
To determine enzyme partitioning, ASL was labeled at amines using succi-
nimidyl ester functionalized Alexa Fluor 647 (degree of labeling: 4.8 dyes/
tetramer), and ATIC was labeled at thiols using C5-maleimide Alexa Fluor
488 (degree of labeling: 1.1 dyes/dimer). Both enzymes were labeled ac-
cording to Invitrogen (Carlsbad, CA) protocol, with the exception that
enzyme concentration was 5 mg/mL instead of the suggested 2 mg/mL to
prevent overlabeling. Upon addition of enzyme to the previously concen-
trated ATPS samples at a final concentration of 100 nM, samples were al-
lowed to mix on a Tube Rotator Unit (VWR International, Radnor, PA) for
1 h or overnight and were phase-separated by centrifugation. The partition-
ing coefficient of each of the enzymes was determined within the ATPS at
a 1:1 PEG/dextran volume ratio (bulk fluorescence measurements) and a
9:1 PEG/dextran volume ratio (confocal microscopy measurements), using
standard curves of each enzyme (ASL and ATIC) in each phase (PEG-rich
Sequential Enzymes in Biphasic Media 2185phase and dextran-rich phase). Bulk fluorescence was measured using a
Fluorolog 3-21 fluorimeter with the software FluorEssence (Horiba Jobin
Yvon, Edison, NJ). Confocal microscopy images were acquired using a
model No. TCS SP5 Laser-Scanning Confocal Inverted Microscope with
a 63 oil objective (Leica Microsystems, Buffalo Grove, IL). Samples
were vortexed before imaging. Enzyme partitioning was measured individ-
ually and with both enzymes together. The predicted concentrations of ASL
and ATIC in each phase at each volume ratio were calculated using the
measured partitioning coefficients, as described by Strulson et al. (34).
The partitioning of SAICAR, AICAR, 10-fTHF, and IMP was measured
individually in a 1:1 PEG/dextran volume ratio at a final concentration of
100 mM. Samples were mixed and phase-separated by centrifugation and
the concentration in each phase was determined by high-performance liquid
chromatography (HPLC). Before analysis, aliquots from each phase were
diluted 2 with 1 M sodium hydroxide.
HPLC analysis of ATPS
The HPLC system consisted of a 1260 Infinity Quaternary Pump and 1260
Infinity Autosampler coupled to a 1260 Infinity thermostated column
compartment (Agilent Technologies, Santa Clara, CA) using a model No.
10-SAX anion-exchange column (0.42  22 cm; Partisil, Peterborough,
Ontario, Canada) and an anion guard cartridge purchased from Mac-Mod
Analytical (Chadds Ford, PA). Absorbance of SAICAR and AICAR were
monitored at 267 nm and IMP was monitored at 250 nm with a model
No. 1260 diode array detector (Agilent Technologies). The metabolites
were eluted with a flow rate of 2.0 mL/min with a 25 min concave gradient
(tG), where n ¼ 7 was used, going from 7.0 mM potassium phosphate, pH
3.0 to 250 mM potassium phosphate, 500 mM KCl, pH 3.8 (Eq. 1) (57)
Once the gradient reached 100%, the method was completed with a
5-min flush of the more concentrated eluent before a 5-min ramp to the
initial conditions. Concentrations were calculated by measuring the peak
area of the samples and standards of known concentration:
% Strong Eluent ¼

t
tG
n
 100: (1)Enzyme assays: Michaelis-Menten kinetics in the individual
phases
ASL assays were conducted with adaptations from a previously described
method (58) using the difference extinction coefficient of 700 M1 cm1
at 267 nm (59) with a model No. 8453 Diode-Array UV-Visible Spectrom-
eter with the software ChemStation (both from Agilent Technologies).
SAICAR was varied from 0 to 100 mM and the ASL concentration was
50 nM. Product formation was measured for 5 min and the slope of the
linear portion of the curve was used to measure activity. The standard Mi-
chaelis-Menten equation (Eq. 2) was used to fit the data in order to deter-
mine KM and Vmax using Igor Pro (WaveMetrics, Portland, OR) nonlinear
regression analysis. The Michaelis-Menten parameters of the AICAR trans-
formylase activity of ATIC were determined by adaptations from a previous
method (54) using a difference extinction coefficient of 19,700 M1 cm1
at 298 nm. The final concentration of ATIC was 50 nM. The KM and Vmax of
AICAR was determined by varying the AICAR concentration from 0 to 100
mM in the presence of 200 mM 10-fTHF. Absorbance measurements were
collected for 5 min and analyzed as described above. The detection of
the inosine monophosphate cyclohydrolase activity of ATIC was beyond
the sensitivity of a spectrophotometric assay in the presence of AICAR
Tfase activity (60). All assays were conducted in triplicate. The Vmax of
the enzymes needed to be adjusted for the mathematical model because
we observed inconsistent activity rates between the activity of the enzyme
in these assays and in the ATPS assays described above, most likely due to
variabilities in enzyme batch purity and/or activity loss over time. We ac-
counted for this by adjusting the enzyme activity to match the ATPS data
described below and measuring the rate of ASL and ATIC at the 100 mMsubstrate by HPLC, and using that rate for the Vmax of the enzymes for
the mathematical model, as the 100 mM substrate is well above the KM of
the enzymes:
V0 ¼ Vmax½S
KM þ ½S: (2)
Enzyme assays: sequential reaction in individual phases and
volume ratios
Sequential assays were conducted in the PEG/dextran volume ratios in
addition to the individual dextran-rich and PEG-rich phases. Concentrations
were 100 nM ASL and ATIC, 100 mM SAICAR, and 400 mM 10-fTHF.
Samples were prepared without the initial substrate SAICAR and homoge-
neously mixed. Upon addition of SAICAR to initiate the reaction, the reac-
tion was mixed on a Tube Rotator Unit (VWR International) and aliquots
were taken at time points and diluted 2 with 1 M sodium hydroxide to
both quench the reaction and dilute the biphasic system to one phase for
HPLC analysis. SAICAR and IMP concentrations were determined by stan-
dard curves prepared for each metabolite.Simulation method
As discussed in the Results and Discussion section, a set of partial differen-
tial equations (PDEs) described the system employing the material conser-
vation equations. To simulate the underlying ATPS, we used the software
package COMSOL 4.3b (COMSOL, www.comsol.com), which solved
the coupled PDEs numerically, using the finite-element method. The min-
imum and maximum element sizes of the created mesh, and the dimension-
less time element in the simulation, were 0.07, 0.5, and 102, respectively.
To satisfy the partitioning expressions in Eq. 4 at the interface, we exploited
a type of change of variables to define new continuous variables at the inter-
face. By solving the new variables, the local concentration profiles during
time were obtained, as discussed in our previous work (37).
Contrary to the ATPS simulation, in PEG-rich or dextran-rich single-
phase simulation, due to symmetry, the mathematical model could be
simplified. In these cases, at every point, the net rates of diffusion were
zero and the concentration of all species was uniform throughout the vol-
ume. As a result, the sequential reactions took place uniformly in the
domain space, and Eq. 3 became a set of ordinary differential equations.
Also, the boundary conditions expressed in Eqs. 4 and 5 were automatically
satisfied in these two cases and could be neglected. To solve the ordinary
differential equation system for PEG-rich or dextran-rich phase, we used
the software package MATLAB 2014a (The MathWorks, Natick, MA),
and specifically the fourth-order Runge-Kutta integration method with
fifth-order timestep error prediction.RESULTS AND DISCUSSION
Fig. 1 illustrates the sequential reaction investigated here,
and the complex reaction medium, in which both enzymes
are concentrated within dextran-rich phase droplets of the
PEG/dextran ATPS. ASL is a tetramer with four active sites
that cleaves SAICAR (5-aminoimidazole-4-(N-succinocar-
boxamide) ribonucleotide) to form AICAR (5-aminoimida-
zole-4-carboxamide ribonucleotide) and fumarate (61).
ATIC is a bifunctional dimer with single active sites for
each enzyme activity (62). The first step uses 10f-THF
(10-formyl tetrahydrofolate) as a cofactor and transfers a
formyl group to the AICAR amine, forming FAICAR (5-for-
mamidoimidazole-4-carboxamide ribonucleotide) and THFBiophysical Journal 109(10) 2182–2194
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FIGURE 1 Reaction schemes. (A) The sequen-
tial reaction of purine biosynthesis enzymes ASL
and ATIC with the substrate, intermediates, cofac-
tors, and product shown. (B) An illustration of the
partitioning of ASL, ATIC, SAICAR, and IMP in
the PEG/dextran ATPS from the start of the reac-
tion to near completion.
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cyclization of FAICAR to make IMP, and releases a water
molecule (63). The AICAR Tfase activity is reversible and
the FAICAR to AICAR reaction is 2–3-fold faster, but the
IMPCH activity is essentially a forward reaction, which
drives the AICAR Tfase reaction toward IMP (63). The bi-
functionality may be advantageous in driving the reaction
forward. It is also worth noting that there is a lack of sub-
strate channeling between the two active sites (63).TABLE 1 Partitioning coefficients of enzymes and substrates
Molecule Partitioning Coefficient
ASLa
Individual 0.1155 0.007
With ATIC 0.115 0.01
ATICa
Individual 0.0045 0.001
With ASL 0.00565 0.0005
SAICARb 0.3185 0.009
AICARb 0.4265 0.009
10-fTHFb 1.0 5 0.3
IMPb 0.435 0.04
aASL and ATIC partitioning was measured at 100 nM.
bSmall molecule partitioning measured at 100 mM.Compartmentalization in the ATPS
We used a 10% (w/w) PEG 8 k, 10% (w/w) dextran 10 k
ATPS that was prepared in a 33 mM Tris buffer, pH 7.4 and
25 mM potassium chloride. A phase diagram for this system
is given in Fig. S1 in the Supporting Material. This composi-
tion resulted in a roughly 3:1 volume ratio of PEG-rich phase:
dextran-rich phase (abbreviated PEG/dextran going forward)
consisting of an upper PEG-rich phase and a lower dextran-
rich phase. The physical properties of the phases differed,
with the dextran-rich phase being approximately twice as
viscous as the PEG-rich phase due to the higher overall poly-
mer concentration of ~28% (w/w) compared to ~18% (w/w)
(see Table S1 in the SupportingMaterial). To control the local
concentration of enzymes, experiments were performed at
specific, nonnative PEG/dextran volume ratios, prepared by
mixing desired amounts of each phase from a large volume
stock ATPS. Most experimental ATPS used in this work
had a smaller volume dextran-rich phase (i.e., PEG-rich/
dextran-rich phase volume ratios 9:1, 19:1, and 49:1), such
that upon mixing, this phase occurred as droplets surrounded
by a continuous PEG-rich phase.
Partitioning was the mechanism used to achieve high
local concentration of enzymes in the dextran-rich phase.
Enzymes typically partition to the dextran-rich phase of a
PEG/dextran ATPS because of their higher affinity for the
more hydrophilic dextran-rich phase (64). Many factors in-
fluence how a protein will partition in a PEG/dextran ATPSBiophysical Journal 109(10) 2182–2194such as protein size, protein shape, surface and overall
charge, and weak affinity interactions with the phase-form-
ing components. While correlations have been found (as
molecular weight and net positive charge of the protein
increases, partitioning increases (65)), partitioning of
individual enzymes of interest must be experimentally
determined. Partitioning is quantified in terms of the parti-
tioning coefficient, K, where K ¼ CP/CD. The value CP is
the concentration in the PEG-rich phase; CD is the concen-
tration in the dextran-rich phase. We measured the partition-
ing of the enzymes and substrates at a 1:1 volume ratio
(Table 1). The metabolites SAICAR, AICAR, and IMP all
partitioned weakly to the dextran-phase. 10f-THF concen-
tration was the same in both phases. The partitioning coef-
ficient of ASL and ATIC was measured individually and in
the presence of the other enzyme because any associations
between the enzymes could change their partitioning
(66,67). In this case, neither enzyme’s partitioning was
significantly affected by the presence of the other. ASL
partitioned 8.7 to the dextran-rich phase, while ATIC par-
titioned much more strongly; it was ~250 more concen-
trated in the dextran-rich phase. We also measured the
enzyme partitioning after 12 h to determine any changes
Sequential Enzymes in Biphasic Media 2187from being in the ATPS for an extended time; no significant
differences were observed. Fig. 2 shows the distribution of
fluorescently-labeled ASL and ATIC enzymes in a 9:1 vol-
ume ratio ATPS; both enzymes accumulate in the dextran-
rich droplet phase and the continuous PEG-rich phase
appears dark. Some aggregation can be seen as bright spots
in the images for both enzymes, particularly for ASL. Ag-
gregation of ASL has been observed previously using static
light scattering in a buffer solution (61).Michaelis-Menten enzyme kinetics in the phases
Michaelis-Menten parameters for ASL and AICARTfase in
the PEG-rich and the dextran-rich phases, as well as non-
crowded buffer solutions, are reported in Table 2. ASL activ-
ity showed a fivefold difference inKM and a small increase in
kcat in the dextran-rich phase while the KM and kcat AICAR
Tfase are within error. Many factors can influence enzyme
activity in macromolecularly crowded solutions, both favor-
ably and unfavorably, such as changes in active site of the
enzyme, changes in substrate chemical activity, or decreased
diffusion in the sample (29,32). Because there was no differ-
ence for KM of AICARwith respect to ATIC activity and it is
similar in size and structure to SACIAR, the most likely
explanation is differences in ASL structure in the PEG-rich
phase, dextran-rich phase and buffer. Further evidence is
the orders-of-magnitude differences in kcat for ASL in buffers
compared to the crowded phases. ASL is sensitive to solution
composition, even in two different buffered solutions, which
underscores the importance of determining enzyme activity
in crowded media. At 100 nM of each enzyme, the activity
of ATIC was ~7 the activity of ASL. This was chosen
because enhanced catalysis of a coupled enzyme reaction
can only be observed when the rate of the second enzyme
is greater than the rate of the first (25).Kinetics of the sequential reaction
We next measured the sequential reaction kinetics in the in-
dividual phases and in the ATPS. We used volume ratiosFIGURE 2 Confocal fluorescence microscopy of the fluorescently
labeled enzymes in the ATPS at a 9:1 volume ratio. Droplets correspond
to the dextran-rich phase, surrounded by a continuous PEG-rich phase.
(Left) Transmitted light (differential-interference-contrast microscopy),
(center) ASL-Alexa Fluor 647, and (right) ATIC-Alexa Fluor 488. Images
have been contrast-adjusted and false-colored to aid visualization. To see
this figure in color, go online.1:1, 9:1, 19:1, and 49:1 so that as the volume of the
dextran-rich phase decreased, the local concentration of
enzyme in that phase would increase. This is advantageous
because the individual phase composition remained con-
stant, and it allowed us to change the enzyme stoichiometry
in each phase without changing to total number of moles of
enzymes in the system. SAICAR, AICAR, and IMP have
overlapping UV spectra; HPLC was used to distinguish
them (Fig. 3). An initial substrate concentration of 100
mM SAICAR was used, as this is an upper estimate of
cellular SAICAR concentration (20–100 mM) (68). The
final product, IMP, is in approximately the same concentra-
tion range (69). Total enzyme concentrations were 100 nM
for ASL and ATIC because these concentrations gave
reproducible results and provided sufficient IMP formation
over the time course of the reaction. Reaction time points
were collected by removing aliquots and adding them to
an equal volume of 1 M sodium hydroxide solution to
stop the reaction and dilute the ATPS to one phase. Metab-
olite concentrations were quantified at each time point
(data points, Fig. 4). For AICAR, we did not observe
any appreciable concentration in the HPLC chromato-
grams, but this was expected given the much higher
activity of ATIC compared to ASL. We observed a slight
increase in product formation at 20 min for the ATPS sam-
ples compared to the individual phases, with the exception
that the 49:1 volume ratio was similar to the dextran-
rich phase. The concentration of IMP at 20 min in the
PEG-rich phase was 78 5 5 mM, while the dextran-rich
phase was 87 5 2 mM. The ATPS samples were
similar: 95 5 1 mM for 1:1, 99 mM 5 1 mM for 9:1,
98 5 1 mM for 19:1, and 86 5 7 mM for 49:1. Overall,
there was a modest effect from colocalization in the
ATPS compared to the sequential reaction in the individual
phases.Mathematical modeling
Next, we quantitatively described the enzyme kinetics in
the individual phases and the ATPS to make predictions
about the enzyme activity under other conditions. A math-
ematical model that we had previously developed for the
enzyme kinetics of glucose oxidase and horseradish perox-
idase in a PEG/citrate ATPS (37) was adapted to fit this
system.
Computational domain
The ATPS reaction medium was modeled as spheres (drop-
lets) of the dextran-rich phase uniformly distributed within a
continuous PEG-rich phase. Dextran-rich phase droplet
radius for the PEG/dextran volume ratios 1:1, 9:1, 19:1,
and 49:1 were measured by microscopy after mixing and
determined to be 90 5 40 mm, 40 5 20 mm, 18 5 5 mm,
and 75 2 mm, respectively. Also, because the domain spaceBiophysical Journal 109(10) 2182–2194
TABLE 2 Michaelis-Menten constants of ASL and ATIC within buffer, PEG-rich phase, and dextran-rich phase
Reference KM (mM) Vmax (mM/min)
b kcat (s
1)
ASL (SAICAR)
40 mM Tris buffer, pH 7.4 (61) 1.8 5 0.1 — 90.25 1.9
50 mM buffer pH 7.5, 150 mM total ionic strength
(NaCl)
(50) 12.85 2 — 259.85 7.8
PEG-rich phase 245 8a 5.45 0.5 0.905 0.08
Dextran-rich phase 55 1a 6.95 0.1 1.155 0.02
AICAR Tfase (AICAR)
66 mM Tris, pH 7.4, 50 mM KCl buffer (63) 10 5 1 — 2.95 0.4
33 mM Tris, pH 7.4, 25 mM KCl buffer (60) 16.85 1.5 different units —
PEG-rich phase 195 6a 395 3 6.55 0.5
Dextran-rich phase 165 5a 425 3 7.05 0.5
aKM measured at 50 nM enzyme.
bVmax adjusted to match activity at 100 nM enzyme used in the other assays (see Materials and Methods).
2188 Davis et al.was symmetric, we used a subsection of the domain to
simplify the calculations.co
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We next described the mass conservation of the system that
involved two phenomena: the enzyme reactions and the
diffusion of the species. The assumption was that the diffu-
sion coefficient of the components was constant within a
phase, and because the average velocity of species was close
to zero, the convective forces could be neglected in the
simulation volume. The mass conservation of species i
was described by the PDE,
vci;j
vt
 Di;jV2ci;j ¼ ri;j; (3)
where i denoted the substrate species, i.e., i ¼ {s,a,f},
which represented SAICAR, AICAR, and IMP (i.e., f ¼
IMP). The phase j ¼ {P,D} represented the PEG-rich or
dextran-rich phase. The concentration and diffusion coeffi-25
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FIGURE 3 HPLC-UV chromatogram at 267 nm of the purine substrates
and products at 100 mM. The peak at 22 min was caused by the salt gradient
(see Materials and Methods). To see this figure in color, go online.
Biophysical Journal 109(10) 2182–2194cients of species i in phase j were denoted by ci,j, and Di,j,
respectively. The values of the diffusion coefficients, Di,j,
were calculated with the Stokes-Einstein equation using
the viscosities of the phases listed in Table S1. To further
elucidate the role that diffusion played in the specific
system, we performed a sensitivity analysis around theco
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FIGURE 4 Sequential reaction kinetics in the individual phases and
ATPS: (A) PEG-rich phase, (B) dextran-rich phase, and the volume ratios
(C) 1:1, (D) 9:1, (E) 19:1, and (F) 49:1. (Red circles) Experimentally deter-
mined SAICAR concentrations. (Blue circles) Experimentally determined
IMP concentrations. (Solid lines) Model predictions of SAICAR (red),
AICAR (green), and IMP (blue); (dashed lines) upper- and lower-limit error
of each trace, based on the Michaelis-Menten parameters in Table 2. Initial
total reaction concentrations were 100 nM ASL, 100 nM ATIC, 100 mM
SAICAR, and 400 mM 10-fTHF; these molecules were distributed
throughout the biphasic solutions according to their partitioning (Table
1). To see this figure in color, go online.
Sequential Enzymes in Biphasic Media 2189calculated values from the Stokes-Einstein equation. We
observed no significant difference in the resulting simula-
tions for a one order-of-magnitude perturbation in the
diffusion coefficient values (see Fig. S2); this analysis
gave us confidence that the simulation predictions would
be insensitive to the chosen values of the diffusion
coefficients.
The net rates of the reactions that involve species i in
phase j were represented by ri,j. The Laplace operator
was denoted by V2 and described the gradient divergence
of the function throughout space. The concentration of
each species i in phase j was dependent on the partitioning
coefficient, Ki, and provided the following boundary
conditions:
ci;Pðr; tÞ

r¼R ¼ Kici;Dðr; tÞ

r¼R: (4)
These boundary conditions ensured that the partitioning
was maintained if a species were consumed or produced.
Because the model was symmetrical, periodic boundary
conditions could be applied to opposite faces of the cube,
ci j a ¼ ci j b;
Fi;j

a
¼ Fi;j

b
;
(5)
where a and b were the two opposite faces of the cube. The
inward flux, F, to phase j of the i component at face l was
represented by
Fi;j

l
¼ Di;jVci;j

l
: (6)
Reaction rate expressions
We modeled ASL and AICAR Tfase using the Michaelis-
Menten equation. The IMPCH activity of ATIC was
assumed to be instantaneous and equal to the rate of the
AICAR Tfase activity. FAICAR could not be detected in
our system by HPLC, so we assumed its concentration
was low (<3 mM). Additionally, The KM of FAICAR has
been reported to be below 1 mM, and it is beyond the sensi-
tivity of most assays (63). The AICAR Tfase activity
required both AICAR and the cofactor 10-fTHF, but we
could model with respect to varying AICAR concentration
only because 10f-THF was in 4 excess. We anticipated
that the concentration of the intermediate, AICAR, would
remain relatively low, because it is used by AICAR
Tfase faster than it is produced by ASL; hence in practice
10f-THF is always at least ~50 higher concentration
than AICAR and by considering it constant, we introduced
negligible absolute errors in the model equations.
For ASL, the rate of SAICAR consumption was equal to
the rate of AICAR production. This rate was solely depen-
dent on ASL and SAICAR concentrations. The rate of
IMP production was equal to the rate of AICAR consump-
tion. AICAR, the intermediate of the sequential assay, wasfirst produced by ASL and consumed by ATIC. The Michae-
lis-Menten reaction rate expressions below described these
conditions:
rs;j ¼ kcat;ASL;jcASL;jcs;j
KM;s;j þ cs;j ; (7)
kcat;ASL;jcASL;jcs;j kcat;ATIC;jcATIC;jca;j
ra;j ¼
KM;s;j þ cs;j  KM;a;j þ ca;j ; (8)
kcat;ATIC;jcATIC;jca;j
rf ;j ¼
KM;a;j þ ca;j : (9)
To aid in the simplicity of the simulation, we nondimen-
sionalized the mass conservation equation and the reaction
rate expressions. These equations and parameter definitions
are given as Eqs. S1–S4 in the Supporting Material and Ta-
ble S2. The simulation output was the concentration profiles
of the reactants and products in time.Comparison of simulation and experimental
results
The simulation concentration profiles are graphed with the
experimental data presented earlier in Fig. 4 for comparison.
The solid lines are the average Michaelis-Menten parame-
ters, and the dashed lines represent the upper and lower ex-
tremes of the standard deviations of the KM and Vmax
parameters. The simulations showed that AICAR reached
a steady-state concentration between 0 and 3 mM, depending
on the case, which is consistent with the lack of detection of
AICAR in the sequential assays. Generally, we saw good
agreement of the modeling results with most of the experi-
mental results. The four curves with deviations were for the
SAICAR curve in the PEG-rich phase, the IMP curve of the
dextran-rich phase, and the 19:1 curves, but the simulation
still reasonably predicted them. This was significant because
the model accurately described the enzyme kinetics in the
individual phases and volume ratios.Effect of compartmentalization on the
sequential rate
As the volume ratio increased, the local concentration
of enzyme (and degree of compartmentalization) in the
dextran-rich phase increased. However, this did not signifi-
cantly improve the rate of final product formation. The re-
sults here are in contrast to the enhanced rates of reaction
observed for a single RNA ribozyme (34) and the enzyme
urease (70) that were each partitioned to the dextran-rich
phase in a PEG/dextran ATPS. The calculated simulation
rates for production of IMP for the first 10 min (linear portion
of each curve) of each phase and volume ratio are given in
Table 3. The model predicted that among the volume ratios,Biophysical Journal 109(10) 2182–2194
TABLE 3 Predicted rate of IMP formation, concentrations of enzymes, and number of moles of enzymes in the individual phases
and volume ratios
ASL ATIC
Sample Rate of IMP Formation (mM/min)a CP (nM) CD (nM) nP (pmol) nD (pmol) CP (nM) CD (nM) nP (pmol) nD (pmol)
PEG-rich phase alone 4.0 100 0 100 0 100 0 100 0
Dextran-rich phase alone 6.3 0 100 0 100 0 100 0 100
1:1 6.1 20 180 10 90 1 199 <1 100
9:1 5.2 55 503 50 50 4 965 3 97
19:1 4.8 71 647 68 32 7 1859 7 93
49:1 4.4 86 782 84 16 17 4181 16 84
These rates were calculated based on constant K values for the individual enzymes listed in Table 1, assuming 100 total pM of each enzyme and 1 mL total
volume. CP, concentration in the PEG-rich phase; CD, concentration in the dextran-rich phase; nP, number of moles in the PEG-rich phase; nD, number of
moles in the dextran-rich phase.
aAverage rate from 0 to 10 min, as predicted by the model.
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FIGURE 5 Simulated IMP production in the ATPS in which the enzyme
activity in the PEG-rich phases is decreased 100. The traces are 1:1
(black), 9:1 (red), 19:1 (blue), 49:1 (green), and PEG-rich phase (orange).
To see this figure in color, go online.
2190 Davis et al.the 1:1 case gave the fastest rate of IMP production. The rate
of IMP production decreased as the volume of dextran-rich
phase decreased. Analysis of the enzyme distribution in the
ATPS as a function of volume ratio, however, explained
the result. Table 3 gives the predicted concentrations and
number of moles of the enzymes in each phase of the volume
ratios. Note that for constant K, although enzyme concentra-
tion increased in the dextran-rich phase as the phase volume
decreased, the fraction of total enzyme in the dextran-rich
phase decreased. At equal volumes of both phases (1:1),
the concentration of ASL in the dextran-rich phase was
180 nM, which increased to 782 nM when the relative vol-
ume of the dextran-rich phase was reduced to one part in
50 (49:1). At the same time, the total amount of ASL in
dextran-rich phase dropped from 90 to 16 pM out of the total
100 pM of ASL present in the reaction. Because ASL is the
slower enzyme (has a smaller Vmax), its concentration had
greater impact on the overall rate of the sequential reaction.
This contrasts with prior work in which ribozyme cleavage
was enhanced 66-fold by compartmentalization in a 100:1
volume ratio PEG/dextran ATPS, compared to dextran-rich
phase alone (34). In the ribozyme experiments, extremely
strong partitioning (nearly 3000-fold greater concentration
in the dextran-rich phase) meant that nearly all of the total
ribozyme remained in the dextran-rich phase even as the vol-
ume of this phase became very small.
We further explored the sequential activity in each of the
phases of the ATPS with the mathematical model in which
we decreased the activity in the PEG-rich phase by a factor
of 100, essentially turning off the reaction in the PEG-rich
phase (Fig. 5). Decreasing the volume of the dextran-rich
phase resulted in a decrease in IMP production, which
demonstrated that the enzyme in the PEG-rich phase
contributed significantly to the amount of IMP produced.
We also performed simulations in which we varied the
enzyme concentrations (Fig. S3). When both enzymes
were at 10 nM, we observed no significant differences be-
tween the individual phases and the volume ratios. Simula-
tions at 10 nM ASL and 100 nM ATIC showed similar
kinetics to the 10 nM ASL and ATIC case, which was ex-Biophysical Journal 109(10) 2182–2194pected because ASL was the slower enzyme. Further simu-
lations of 100 nM ASL and 10 nM ATIC showed that the
AICAR intermediate built up to an appreciable extent
because the activity of ATIC became the limiting rate.Probing changes in enzyme and substrate
partitioning with the mathematical model
Next, we used the mathematical model to explore how
changes in enzyme partitioning would affect the reaction
rate. In this experimental system, the enzymes partition
because of nonspecific interactions with the phase-forming
components. In the cell, however, enzyme localization is
controlled through a number of different means, such as
weak and strong binding interactions, phosphorylation
states of enzymes, and conformational changes. We investi-
gated IMP formation by simulating changes in the partition-
ing of both ASL and ATIC using the mathematical model.
Fig. 6 shows the effect on IMP formation from varying
the enzymes from equal concentration in both phases
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FIGURE 6 Effect of simulated changes in enzyme partitioning at each of
the volume ratios. (A) 1:1, (B) 9:1, (C) 19:1, and (D) 49:1. (Bottom to top:
black traces, K ¼ 1; red traces, K ¼ 0.1; blue traces, K ¼ 0.01; and green
traces, K ¼ 0.001.) As the partitioning is increased to the dextran-rich
phase, the IMP production is increased for each volume ratio. To see this
figure in color, go online.
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FIGURE 7 The effect of changes in substrate partitioning. (A) K ¼ 0.1
for all small molecules (SAICAR, AICAR, 10-fTHF, IMP) and (B) is
K ¼ 0.01. The activity decreased as the volume ratio is increased (from
top to bottom): 1:1 (black), 9:1 (red), 19:1 (blue), and 49:1 (green). (C)
K ¼ 0.001 for both enzymes with experimental K (black) and K ¼ 0.01
(red) for the small molecules. To see this figure in color, go online
Sequential Enzymes in Biphasic Media 2191(K ¼ 1) to 1000 more concentrated in the dextran-rich
phase (K ¼ 0.001). At each volume ratio, as the partitioning
of the enzymes increased, the rate of IMP formation
increased. No further enhancement was observed by simu-
lating the partitioning beyond K ¼ 0.001. While the en-
hancements here were rather small, increased local
concentrations under these conditions led to increased prod-
uct formation. Recently, it was reported that purinosome-
containing cells had increased purine biosynthesis
compared to cells without purinosomes; a nearly threefold
increase in IMP cellular concentration was observed
(4,40,45). These results and our modeling results are consis-
tent with the hypothesis that increased local concentration
of the sequential enzymes leads to an increase in final prod-
uct formation.
We explored the effect of changes in both substrate
partitioning and enzyme concentration. We increased the
partitioning of the small molecules (SAICAR, AICAR,
10f-THF, and IMP) to the dextran-rich phase, using K ¼
0.1 and K¼ 0.01, and the experimental enzyme partitioning
coefficients (Fig. 7, A and B). We observed a trend as we
have with the previous conditions in Fig. 4, in that the
rate of IMP decreased as the volume ratio increased. IMP
formation was decreased in the K ¼ 0.01 condition
compared to K ¼ 0.1 because there was less substrate avail-
able to the active enzyme in the PEG-rich phase. These re-
sults indicated that because functional enzymes are present
in both phases, there was not a large advantage to substrate
localization in this PEG/dextran model system with ASL
and ATIC at the experimental partitioning coefficients.
Next, we simulated changes in which both the enzymes
and substrates partitioned strongly to the dextran-rich phase
and the enzyme concentrations were varied. We held eachenzyme partitioning at K ¼ 0.001 and used partitioning
of the substrates K ¼ 0.01. We used enzyme concentrations
of 100 nM (experimental concentration) and 10 nM. At
100 nM enzyme concentration, increasing the substrate par-
titioning did not increase the overall rate to an appreciable
extent in the volume ratios (Figs. 7 C and S4). At 10 nM
enzyme concentration, the concentration of intermediate
AICAR was decreased and the concentration of final prod-
uct IMP was increased for the 49:1 case compared to the
individual phases; SAICAR concentration was similar for
the dextran-rich phase and the volume ratios (Fig. S5).
There was a kinetic advantage to localizing ATIC at this
concentration.
Here, substrate location and enzyme concentration had an
impact on the sequential rate. Enzyme and small molecule
localization is important in vivo in the form of substrate
channeling (21,71). Substrate channeling has been observed
under other experimental model conditions (1,14,18), but
we did not believe that was happening to an appreciable
extent here because the enzymes were free to diffuse inde-
pendently from each other in the compartment. Cluster-
mediated channeling has also been proposed (4). Enzymes
and metabolites are not likely to be found distributed evenly
throughout an entire cell because of specific interactions
with other biomolecules, and they are involved with meta-
bolic processes that only occur in specific areas (2).CONCLUSIONS
The presence of liquid-like compartments in cytoplasm
and nucleoplasm of biological cells suggests new waysBiophysical Journal 109(10) 2182–2194
2192 Davis et al.to compartmentalize and potentially control metabolic
pathways. These liquid organelles are an attractive possi-
bility for transient multienzyme assembly because they
allow for reversible localization of the enzymes based on
formation/dissolution of the liquid compartment. Our
experimental and computational model for compartmental-
ization of the purine enzymes to a liquid compartment did
not result in a large increased flux of the sequential reac-
tion. Instead, an increase in the number of total moles of
ASL in the PEG-rich phase compared to the dextran-rich
phase caused a decrease in rate of the final product, IMP,
as the volume ratio was increased. Our computational
model allowed us to consider systems beyond those readily
accessible to experiment, including conditions more closely
relevant to the purine de novo pathway and other multien-
zyme pathways in vivo. Significantly increased reaction
rates could only be realized if essentially all active copies
of the enzyme were localized exclusively to compartments.
For the PEG/dextran ATPS used here, which intentionally
lacked any affinity interactions with the enzymes (although
ASL partitioning led to 8.7-fold higher local concentra-
tion), this compartmentalization was not strong enough to
result in overall rate increases. Recent work by Levy
et al. (46) has shown that enzymes partition between the
cytoplasm and the membrane of yeast cells. They showed
that the protein there was an ~9.5-fold difference in concen-
tration of proteasome subunit Pre9 between the cytoplasm
and the membrane. In total, 566 other proteins had at least
a fourfold difference in concentration between the two lo-
cations. In principle, selective biorecognition partners pre-
sent within an intracellular liquid organelle could provide
the necessary local concentration to increase flux for the
sequential reaction in vivo. For the purinosomes, interac-
tions with other purine biosynthetic enzymes and unidenti-
fied factors are thought to be important in localization (41).
More generally, intracellular liquid phases are rich in both
nucleic acids and proteins that could provide ample oppor-
tunity for strong affinity partitioning. Additionally, the cell
could modulate an enzyme’s activity depending on its
cellular location. Future work in this area could explore
using phase-forming components (such as proteins and nu-
cleic acids) that have stronger interactions with the en-
zymes, which would have the potential to change enzyme
activity and local enzyme concentration. In the specific
case of the de novo purine pathway, we note that only the
last two proteins were included in this study. Greater kinetic
advantages may be expected for the full pathway, particu-
larly if it assembles onto a scaffold such as the cytoskel-
eton, as has been proposed (4,40).SUPPORTING MATERIAL
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